FMS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Stats
Dagens volum	368 908
Gjennomsnittsvolum	454 112
Markedsverdi	12.15B
EPS	$0 ( 2024-02-20 )
Neste inntjeningsdato	( $0.260 ) 2024-05-14
Last Dividend	$0.618 ( 2023-05-17 )
Next Dividend	$0 ( N/A )
P/E	22.76
ATR14	$0.00700 (0.03%)

Volum Korrelasjon

Lang: 0.09 (neutral)

Kort: -0.12 (neutral)

Signal:(76.092) Neutral

Fresenius Medical Care AG Korrelasjon

10 Mest positive korrelasjoner
DMYS	0.973
CXAC	0.97
ALCC	0.962
AFTR	0.96
BMAC	0.96
MTVC	0.959
MTH	0.959
TRCA	0.958
BSAQ	0.957
PNTM	0.957

10 Mest negative korrelasjoner
GRUB	-0.954
PAK	-0.953
CCOR	-0.94
UNL	-0.936
TPL	-0.936
DBMF	-0.933
RSF	-0.931
UNG	-0.931
GAZ	-0.931
RKLY	-0.93

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fresenius Medical Care AG Korrelasjon - Valuta/Råvare

-0.30
( neutral )

-0.48
( neutral )

0.00
( neutral )

0.56
( weak )

0.45
( neutral )

Fresenius Medical Care AG Økonomi

Annual	2023
Omsetning:	$19.45B
Bruttogevinst:	$4.93B (25.32 %)
EPS:	$1.700

FY	2023
Omsetning:	$19.45B
Bruttogevinst:	$4.93B (25.32 %)
EPS:	$1.700

FY	2022
Omsetning:	$19.40B
Bruttogevinst:	$5.31B (27.37 %)
EPS:	$2.30

FY	2021
Omsetning:	$17.62B
Bruttogevinst:	$5.08B (28.82 %)
EPS:	$1.655

Financial Reports:

No articles found.

Fresenius Medical Care AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.618 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fresenius Medical Care AG Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.29 - Stable (5.77%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0930	1998-06-08
Last Dividend	$0.618	2023-05-17
Next Dividend	$0	N/A
Payout Date	2023-06-01
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	$10.47	--
Avg. Dividend % Per Year	1.85%	--
Score	3.96	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.29
Div. Directional Score	8.17	--

Next Divdend (Est)
(2025-04-02)

$0.626 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.96

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
1998	$0.0930	0.85%
1999	$0.104	0.86%
2000	$0.111	0.80%
2001	$0.121	0.87%
2002	$0.125	1.21%
2003	$0.168	2.48%
2004	$0.253	2.11%
2005	$0.239	1.79%
2006	$0.244	1.35%
2007	$0.314	1.39%
2008	$0.416	1.58%
2009	$0.375	1.57%
2010	$0.408	1.50%
2011	$0.475	1.65%
2012	$0.456	1.30%
2013	$0.490	1.43%
2014	$0.533	1.53%
2015	$0.438	1.20%
2016	$0.440	1.07%
2017	$0.514	1.21%
2018	$0.632	1.21%
2019	$0.655	2.01%
2020	$0.707	1.91%
2021	$0.834	1.96%
2022	$0.709	2.17%
2023	$0.618	3.84%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0281	1.500	9.44	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0161	1.200	9.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0398	1.500	-0.669	-1.004	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.424	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.45	[0.8 - 2.5]
cashRatioTTM	0.230	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0.355	-1.500	4.08	-6.12	[0 - 0.6]
interestCoverageTTM	3.47	1.000	9.83	9.83	[3 - 30]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.63	2.00	6.69	10.00	[0 - 20]
debtEquityRatioTTM	0.885	-1.500	6.46	-9.69	[0 - 2.5]
grossProfitMarginTTM	0.253	1.000	9.11	9.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.0710	1.000	-0.580	-0.580	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.218	1.000	9.90	9.90	[0.2 - 2]
assetTurnoverTTM	0.573	0.800	9.51	7.61	[0.5 - 2]
Total Score				11.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.06	1.000	9.08	0	[1 - 100]
returnOnEquityTTM	0.0398	2.50	-0.430	-1.004	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.63	2.00	7.79	10.00	[0 - 30]
dividendYielPercentageTTM	3.30	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.425	1.500	3.84	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.135	1.000	9.12	0	[0.1 - 0.5]
Total Score				5.29

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.